 |
Company Profile
About Idealp-Pharma
|
|
History
Idealp-Pharma is a self-funded company which was founded in 2000 by Serge Petit, PhD. The company has built a reputation for delivering exclusive and confidential chemistry services to the pharmaceutical industry and biotech industries as support of corporate drug discovery activities. In 2003, Idealp-Pharma established its in-house computational chemistry capabilities. In 2004, Idealp-Pharma acquired a biology department for screening and exploratory in vitro ADMET.
Idealp-Pharma now employs approximately 30 staff.
Idealp-Pharma has won the confidence of many well-known companies, including: Addex Pharmaceuticals, Anaconda Pharma, Bayer, Cellvir, Cytomics Pharmaceuticals, E.O.S., Exonhit Therapeutics, Faust Pharmaceuticals, Fournier Pharma, GlaxoSmithKline, Galapagos, Guerbet, Institut Lejeune, Laboratoires Pierre Fabre, Merck KGaA, Mutabilis, Nicox, Obetherapy, Sanofi-Synthelabo, Sepal Pharma, Servier, Solvay, Texinfine, Theraptosis, Trophos, Urogene, Vivalis, the Zambon Group…
Facilities
Based in Lyon (France), Idealp-Pharma’s purpose-built lab covers a total of 2000 square meters. The chemistry research infrastructure comprises 1000 square meters of laboratory space equipped for organic synthesis and parallel synthesis, togeteher with analytical facilities. The biology department covers 500 square meters and comprises a broad range of technology platforms. |
|
